$IBO Potential Healthcare Stocks That Are Making Investors Insane About The ProfitLongby spoulhennryy0
Efficacy of NCP-01 a futuristic product by Hemostemix Neuropathic pain syndromes can be treated with NCP-01 and its autologous stem cell technology, which can treat disorders of the central and peripheral nervous systems. Spinal cord injury, chronic brainstem injury, traumatic brain injury, and peripheral nerve injury are all examples of traumatic injuries and many more by dasranc7770
“An investor without investment ideas is like a traveler without so keep Update your ideas with the new addition of $IBO Update your watch list with the new addition of $IBO Stocks veered from bearish to bullish day by day & leaving investors amazed in the Tsx_v market Longby spoulhennryy0
$HEM grants universal field license to PreCerv Inc. Hemostemix recently granted the global field license of use of NCP-01 and its autologous stem cell therapies to PreCerv Inc. its wholly owned subsidiary to aid patients with peripheral and central nervous system conditions. by dasranc7770
The Universal Ibogaine MissionUniversal Ibogaine is working with Health Canada to undertake a planned clinical trial in Canada to demonstrate the safety and efficacy of the Ibogaine treatment protocol for opioid use disorder.by immediateSnow302261
$IBO soon to commission ultra- modern addiction treatment centreAt the Kelburn Clinic, UI is developing a cutting-edge holistic addiction treatment protocol that, when combined with the anticipated ibogaine detox programme, will transform the way we treat addiction and dramatically enhance the lives of individuals and families plagued by addiction.by immediateSnow302260
UI CEO’s thrilled to work with Blue Digital Media"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." Alike Blue Digital Media’s expertise radarby immediateSnow302260
Nick Karos excited by listing of UI on Frankfurt stock exchange Universal Ibogaine Inc. CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedelic medications, Germany has a reputation for innovation and leadership." Longby sparrowhennry9510
$IBO CO-Founder with flawless recordDr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has effectively administered over 3,700 ibogaine treatments, more than any other doctor in the world, at an independent clinic in Cancun, Mexico, where he is a partner.by immediateSnow302260
$IBO contract with blue digital media dictates further benefitsBlue Digital will be paid USD 27,000 for a three-month commitment beginning June 13, 2022. Additionally, Blue Digital will get 450,000 company's stock options to purchase common shares of the Company, with an exercise price of $0.10 per share, a three-year term, and one-third vesting at the conclusion of each month of service.by immediateSnow302260
$HEM with a breath taking stock performance on TSX-V$HEM is currently trading on the TSX-V effortlessly at $0.28 with no such loss percentage recorded yet and is expected to rise significantly in the upcoming week effectively.by immediateSnow302260
$HEM market cap mounts to $19.7 Million strong$HEM have developed and established a firm market cap which has been on the rise steadily since the listing of the stock on TSX-V, currently the cap valuation is $19.773 Million.by immediateSnow302260
$HEM reports non-brokered private placement of 15 million units Hemostemix disclosed a non-brokered private offering of about 15 million units to shareholders, priced in the context of the market, with each unit consisting of one common share and one common share purchase warrant.by dasranc777110
Presentation of Dr. Alberto Sola on the Research to Reality ConfDr. Alberto Sola, the co-founder of $IBOGF is going to present his latest findings in a panel titled “Ibogaine Hydrochloride and Acute Opioid Detox”.Longby sparrowhennry951110
Hemostemix Inc. interest payment on convertible debentureHemostemix Inc. announced that it will pay interest of $84,804.40 by issuing 446,339 Common Shares, using the March 2, 2022 closing price of $0.19 per share, to the convertible debenture holder in satisfaction of interest due on the outstanding principal amount of $2,500,000 for the period from inception, June 11, 2021, to December 31, 2021.by immediateSnow302260
$IBO Market InsightsUniversal Ibogaine Inc. is a Canadian Life science company trading at TSX-V with the ticker symbol $IBO currently sits at $0.0450 with volume around $25K+. invest now for getting higher returnLongby spoulhennryy110
$PQE moving ahead fiercely with an unstoppable forceThe stock today observed a brief rise in the value per share since its previous close, and the shares are actively being traded on TSX-V at $.245 per unitPby immediateSnow302260
$PQE moving ahead fiercely with an unstoppable forceThe stock today observed a brief rise in the value per share since its previous close, and the shares are actively being traded on TSX-V at $.24 per unitPby immediateSnow302260
$PQE Market AwarenessPetroteq Energy Inc. is a fully integrated oil and Gas Company trading in TSX-V, Currently sits at $0.26 with market volume of 971.67K.Pby immediateSnow302260
$PQE trading hours over the TSX-V platform The stock has been on a good run and has received a remarkable hike over the volume and price which currently lands at $0.28 per share have obtained a volume of 2.26 million+.Pby immediateSnow302260
Today’s price metricsThe market has begun with an excellent initial capital of $0.255 which later on took a move to $0.28 per share. Petroteq has acquired a volume of 2.05 million in the complete trading hour.Pby immediateSnow302260
$PQE- 52 consecutive week estimation over the stock price $PQE is currently well-positioned over the TSX-V with a remarkable performance of volume pick up, offering each share value of $0.255 today. While taking a brief analysis of straight 52 consecutive weeks is recorded as 0.41 the highest and 0.11 as the lowest offers as per the records.Pby immediateSnow302260
$PQE trade volume and market cap valuationPetroteq is an energy-based stock which precisely deals with the oil extraction, listed on TSX-V, at a buyout price of $0.255 has obtained a volume of $325.42K so far. The market capitalization is worth a total of 195.7 million+.Pby immediateSnow302260